m+Medelevator.RU
← Поиск публикаций
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026

Folate-Targeted polymeric micelles enhance the anti-glioma efficacy of pterostilbene in an orthotopic rat model.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Yang Xiaobo, Sun Yuze, Jin Huan, Zhou Hailin, Yang Yunqiao, Su Yanan, Wang Jinan, Zhao Zhiwei, Yu Wenyao, Wu Moli, Wang Qian, Liu Conghongting, Sun Wen, Wang Changyuan, Wang Chong, Lv Li, Li Mingzhan, Ning Jing, Isakson Brant E, Wang Yinan, Shu Xiaohong

Аннотация

The clinical translation of Pterostilbene, a neuroactive stilbene with broad therapeutic potential, is hampered by its poor aqueous solubility and insufficient brain accumulation. To address these limitations, we developed a folate receptor-targeted polymeric micelle system (F-Pt/M) using poly (ethylene glycol)-block-poly (ε-caprolactone) copolymers. The optimized F-Pt/M exhibited a small hydrodynamic diameter (∼133 nm), high drug loading, and increased the apparent solubility of pterostilbene by 25-fold. In folate receptor-expressing U251 and RG-2 glioma cells, F-Pt/M significantly enhanced cellular uptake via folate-mediated endocytosis and showed superior cytotoxicity compared to non-targeted micelles. In an orthotopic RG-2 glioma model, intravenous administration of F-Pt/M improved brain accumulation and prolonged median survival by 76.5% relative to free drug. Mechanistically, the enhanced anti-glioma efficacy was associated with induction of apoptosis and inhibition of the STAT3 signaling pathway. These findings establish folate-targeted micelles as a robust and versatile nanoplatform for delivering poorly soluble bioactive compounds to the brain, with pterostilbene representing a promising candidate for further neuro-oncological development.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты